 | |
| Clinical data | |
|---|---|
| Other names | G-475 |
| Routes of administration | Oral[1] |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 83%[1] |
| Metabolism | Hepatic |
| Eliminationhalf-life | 6.1-11.2 hours[1] |
| Excretion | Renal[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.007.371 |
| Chemical and physical data | |
| Formula | C13H18N2O3 |
| Molar mass | 250.298 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Heptabarb (INN;Eudan,Medapan,Medomin,Noctyn), also known asheptabarbitone (BAN) orheptabarbital, is asedative andhypnoticdrug of thebarbiturate family.[2][3] It was used inEurope for the treatment ofinsomnia from the 1950s onwards, but has since been discontinued.[2][3]
